首页 > 抗体蛋白 > 抗体
Purified anti-mouse CD25 Antibody
产品名称:
Purified anti-mouse CD25 Antibody
产品类别:
抗体
产品编号:
102002
产品应用:
102002
[价格]
规格 价格 库存
500µg ¥ 1568 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
IL-2-dependent cytolytic mouse T-cell clone B6.1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F - Verified
IP, Block, Depletion - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, in vitro blocking of IL-2 binding to low- and high-affinity receptors1-4, growth inhibition of IL-2-dependent T-cell lines1-4, in vivo depletion of CD25+CD4+ Treg cells5-8,10, and immunohistochemical staining of acetone-fixed frozen sections2. PC61 antibody recognizes a different epitope than 3C7 antibody (Cat. No. 101902).?For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF? purified antibody (Cat. No. 102040) with endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered.?

Application References

(PubMed link indicates BioLegend citation)
  1. Lowenthal JW, et al. 1985. Nature 315:669. (IP, Block)
  2. Ceredig R, et al. 1985. Nature 314:98. (IP, IHC, Block)
  3. Lowenthal JW, et al. 1985. J. Immunol. 135:3988. (Block)
  4. Moreau JL, et al. 1987. Eur. J. Immunol. 17:929. (Block)
  5. Takahashi T, et al. 2000. J. Exp. Med. 192:303. (Deplete)
  6. Onizuka S, et al. 1999. Cancer Res. 59:3128. (Deplete)
  7. Lei TC, et al. 2005. Blood 105:4865. (Deplete)
  8. Pasare C, et al. 2004. Immunity 21:733. (Deplete)
  9. León-Ponte M, et al. 2007. Blood 109:3139.
  10. Cao OW, et al. 2007. Blood doi:10.1182/blood-2007-02-073304. (Deplete)
  11. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719.
  12. Liu F, et al. 2011. Arch Toxicol. 85:1383. PubMed
  13. Anguela XM, et al. 2013. Diabetes. 62:551. PubMed
Product Citations
  1. Ma F, et al. 2020. Theranostics. 5.784722222. PubMed
  2. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  3. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  4. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  5. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  6. Muhammad F, et al. 2020. Front Immunol. 975:11. PubMed
  7. Do DC, et al. 2019. JCI Insight. 4:e126832. PubMed
  8. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  9. Gottschalk R, et al. 2012. Proc Natl Acad Sci U S A. 109:881. PubMed
  10. Wang J et al. 2018. Cell. 176(1-2):334-347 . PubMed
  11. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  12. Liu F, et al. 2017. Front Immunol. 8:414. PubMed
  13. Liu F, et al. 2011. Arch Toxicol. 85:1383. PubMed
  14. Hua J, et al. 2018. Sci Rep. 5.235416667. PubMed
  15. Oba T, et al. 2021. J Immunother Cancer. 9:. PubMed
  16. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  17. Tan W, et al. 2021. Front Immunol. 12:653803. PubMed
  18. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  19. Park GY, et al. 2020. Immune Netw. e43:20. PubMed
  20. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  21. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  22. Kamio K, et al. 2018. Respir Res. 0.840972222. PubMed
  23. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  24. Anguela X, et al. 2013. Diabetes. 62:551. PubMed
  25. Yates K, et al. 2018. Proc Natl Acad Sci U S A. 115:2162. PubMed
  26. Oyarce K, et al. 2018. Front Immunol. 9:112. PubMed
  27. Zander R, et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.10.077. PubMed
  28. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  29. Murphy SF, et al. 2017. Pain. 158:1517. PubMed
  30. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  31. Muhammad F, et al. 2020. J Autoimmun. 111:102441. PubMed
  32. Kakaradov B, et al. 2017. Nat Immunol. 18:422. PubMed
  33. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  34. Yang J, et al. 2019. Front Immunol. 2.492361111. PubMed
  35. Benson M, et al. 2007. J Exp Med. 204:1765. PubMed
  36. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  37. K?stele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
RRID
AB_312851 (BioLegend Cat. No. 102002)

Antigen Details

Structure
Forms high affinity IL-2R with IL-2Rβ (CD122) and IL-2Rγ (CD132), 55 kD
Distribution

Activated T cells and B cells, thymocyte subset, pre-B cells, T regulatory cells

Function
IL-2 receptor
Ligand/Receptor
IL-2
Cell Type
B cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References
  1. Taniguchi T, et al. 1993. Cell 73:5-8.
  2. Waldmann TA. 1991. J?Biol?Chem. 266:2681-4.
  3. Read S, et al. 2000. J Exp?Med. 192:295-302.
  4. Lowenthal JW, et al. 1985. J?Immunol. 135:3988-94.
Gene ID
16184 View all products for this Gene ID
UniProt
View information about CD25 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线